Acute myocardial infarction and diabetes mellitus: Is admission glycosylated hemoglobin predictive of one-year major adverse cardiovascular events?

Introduction In diabetic patients with acute myocardial infarction (MI), prognostic value of glycosylated hemoglobin (HbA 1c) remains debated. Objective In a large observational study, we aimed to identify the prognostic value of HbA 1c measured on admission for acute MI in diabetic patients regarding one-year major adverse cardiovascular events (MACE). Methods From the RICO survey database, all consecutive patients with or without known diabetes with acute MI (N = 3005) from January 2001 to June 2016 were included. We divided our population into 4 quartiles: HbA 1c ≤ 6.5% (N = 807), 6.5–7% (N = 722), 7.2–8.1% (N = 748), ≥ 8.2% (N = 728) for the analysis. Results On admission, median age was 73 years old, median HbA 1c and glucose were 7.0% and 9.6 mmol/L. Compared to HbA 1c ≤ 6.5% group, HbA 1c ≥ 8.2% group was made up of younger persons (74 vs. 70 years old, P < 0.001), had most important body mass index > 30 kg/m² (221 (28%) vs. 241 (33%), P = 0.041), had less important high blood pressure rate (610 (76%) vs. 508 (70%), P = 0.016) and had a stronger anti-diabetic treatment (insulin plus oral anti-diabetic medication: 44 (6%) vs. 176 (24%), P < 0.001). Regarding the clinical data, HbA 1c ≥ 8.2% group had more STEMI (372 (46%) vs. 395 (54%), P = 0.002), more multi-vessel disease (446 (60%) vs. 455 (67%), P = 0.007) but lower GRACE score (156 vs. 150, P = 0.020) than HbA 1c ≤ 6.5% group. We did not observed any difference concerning one year MACE between the 4 groups (HbA 1c ≤ 6.5%: 243 (30.1%); 6.6–7.0%: 227 (31.4%); 7.1–8.1%: 246 (32.9%); ≥ 8.2%: 239 (32.8%), P = 0.6). Conclusions Even in case of extreme glycometabolic chronic derangement, our results showed that the initial HbA1c has no one-year prognostic significance value after acute MI in our large diabetic population. However, these patients remain in a high-risk cardiovascular population and need close multidisciplinary follow-up. The chronical hyperglycemia prognostic value should be studied over a much longer period. [ABSTRACT FROM AUTHOR]